'Approved drugs' presentation slideshows

1.04k views • 82 slides

Pharmacy Issues: 2004

Pharmacy Issues: 2004. Elizabeth Curry-Galvin, DVM Assistant Director, Scientific Activities AVMA-Schaumburg Egalvin@avma.org. Topics Compounding Ethical Products Internet Pharmacies. Context Business Legal Ethical Reminder Allegations, No Names Policy vs. Not

516 views • 41 slides

Pharmacy Issues: 2004

Pharmacy Issues: 2004. Elizabeth Curry-Galvin, DVM Assistant Director, Scientific Activities AVMA-Schaumburg Egalvin@avma.org. Topics Compounding Ethical Products Internet Pharmacies. Context Business Legal Ethical Reminder Allegations, No Names Policy vs. Not

516 views • 41 slides

Pharmacy Issues: 2004

Pharmacy Issues: 2004. Elizabeth Curry-Galvin, DVM Assistant Director, Scientific Activities AVMA-Schaumburg Egalvin@avma.org. Topics Compounding Ethical Products Internet Pharmacies. Context Business Legal Ethical Reminder Allegations, No Names Policy vs. Not

498 views • 41 slides

Pharmacy Issues: 2004

Pharmacy Issues: 2004. Elizabeth Curry-Galvin, DVM Assistant Director, Scientific Activities AVMA-Schaumburg Egalvin@avma.org. Topics Compounding Ethical Products Internet Pharmacies. Context Business Legal Ethical Reminder Allegations, No Names Policy vs. Not

472 views • 41 slides

Using Multiple Methods and Data Sources to Analyze Complex Cancer Research Portfolios

Using Multiple Methods and Data Sources to Analyze Complex Cancer Research Portfolios. Joshua Schnell Discovery Logic, A Thomson Reuters Business Co-Authors: Elizabeth Hsu, Jim Corrigan (NIH), Sandeep Patel, Lauren Taffe, Duane Williams (Discovery Logic). Data-driven portfolio management .

196 views • 19 slides

Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Anal

iGATE RESEARCH report entitled Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Analysis to 2019 provides an in-depth analysis of the drugs, pipeline drugs and the key players that will shape the future of Hepatitis C Drugs Market. This 113 page report enriched with 27 Figures and 1 Table studies the Hepatitis C Drug Market Landscape. This Report is analyzed from four view points: Approved drugs sales, Pipeline drugs sales, Company Wise Clinical Trial Analysis and Deals and Acquisitions in Hepatitis C Landscape. Hepatitis C - Approved Drugs sales and Forecast Analysis (To 2019) 1. Pegasys 2. Pegintron 3. Incivek 4. Victrelis 5. Copegus 6. Rebetol 7. Virazole 8. Intron A 9. Olysio 10. Sovaldi 11. Daklinza Hepatitis C - Pipeline Drugs Sales and Forecast (To 2019) 1. HCV Franchise (Bristol-Myers Squibb) 2. HCV Franchise (AbbVie) 3. PEG-Interferon Lambda 4. Vaniprevir 5. MK-8742 MK-5172 33 6. Mericitabine or RG7128 7. Sunvepra (Asunaprevir) 8. ABT-450/r Ombitasvir (ABT-267) Dasabuvir (ABT-333) Company Wise - Hepatitis C Pipeline Drugs Clinical Trials 1. Roche 2. AbbVie 3. Gilead Sciences 4. Achillion 5. Merck 6. Tibotec / Janssen 7. Bristol-Myers Squibb (BMS) 8. Vertex 9. Genentech

617 views • 14 slides

Aarkstore - Metastatic Hormone Refractory

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer. Browse full report @ http://bit.ly/1Ms2HSk

289 views • 11 slides

Botanical and Plant Derived Drugs Market - Global Industry A

205 views • 6 slides

Global Systemic Lupus Erythematosus Market is expected to grow at a CAGR of 6.55% by the end of 2025. Due to the new biological therapies in the developmental pipeline, revenue is set to be boosted by these advancements.

64 views • 6 slides

New clinical research rules have brought focus on a number of aspects, which will set a beautiful landscape for the Indian clinical research industry. So, get yourself enrolled for clinical research diploma courses in Bangalore.

24 views • 2 slides